• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

酵母聚糖 A 通过刺激海马小胶质细胞在慢性应激小鼠中产生快速而持久的抗抑郁作用。

Zymosan A produces a rapid and sustained antidepressant effect in chronically stressed mice by stimulating hippocampal microglia.

机构信息

Department of Pharmacology, School of Pharmacy, Nantong University.

Invasive Technology Department, Affiliated Hospital 2 of Nantong University, First People's Hospital of Nantong City, Nantong, China.

出版信息

Behav Pharmacol. 2023 Sep 1;34(6):318-329. doi: 10.1097/FBP.0000000000000738. Epub 2023 Aug 2.

DOI:10.1097/FBP.0000000000000738
PMID:37530136
Abstract

Recent studies had reported that compounds that stimulate microglia could be developed as potential drugs for the treatment of depression due to their reversal effect on depression-like behaviors in chronically stressed mice. Zymosan A is a cell wall preparation of Saccharomyces cerevisiae composed of β-glucans. Based on its immuno-stimulatory activities, we hypothesized that zymosan A might have a therapeutic effect on depression. Our results showed that a single injection of zymosan A 5 h before behavioral tests at a dose of 1 or 2 mg/kg, but not at a dose of 0.5 mg/kg, reversed chronic unpredictable stress (CUS)-induced depression-like behaviors in mice in the tail suspension test, forced swimming test, and sucrose preference test. Time-dependent analysis showed that the antidepressant effect of zymosan A (2 mg/kg) in CUS mice became statistically significant at 5 and 8 h, but not at 3 h, and persisted for at least 7 days. Fourteen days after a single injection of zymosan A, no antidepressant effect was observed anymore. However, the disappeared antidepressant effect of zymosan A was restored by a second zymosan A injection (2 mg/kg, 5 h) 14 days after the first zymosan A injection. Stimulation of microglia was essential for the antidepressant effect of zymosan A because pre-inhibition of microglia by minocycline or pre-depletion of microglia by PLX3397 prevented the antidepressant effect of zymosan A. Based on these effects of zymosan A, zymosan A administration could be developed as a new strategy for the treatment of depression.

摘要

最近的研究报告称,由于能够逆转慢性应激小鼠的抑郁样行为,刺激小胶质细胞的化合物可能被开发为治疗抑郁症的潜在药物。酵母聚糖 A 是一种由 β-葡聚糖组成的酿酒酵母细胞壁制剂。基于其免疫刺激活性,我们假设酵母聚糖 A 可能对抑郁症有治疗作用。我们的结果表明,在行为测试前 5 小时单次注射 1 或 2mg/kg 剂量的酵母聚糖 A,但不是 0.5mg/kg 剂量,可逆转慢性不可预测应激(CUS)诱导的小鼠悬尾试验、强迫游泳试验和蔗糖偏好试验中的抑郁样行为。时间依赖性分析表明,酵母聚糖 A(2mg/kg)在 CUS 小鼠中的抗抑郁作用在 5 和 8 小时时具有统计学意义,但在 3 小时时没有,并且至少持续 7 天。单次注射酵母聚糖 A 14 天后,不再观察到抗抑郁作用。然而,在第一次注射酵母聚糖 A 14 天后再次注射酵母聚糖 A(2mg/kg,5 小时)恢复了其消失的抗抑郁作用。小胶质细胞的刺激对于酵母聚糖 A 的抗抑郁作用是必不可少的,因为米诺环素预先抑制小胶质细胞或 PLX3397 预先耗尽小胶质细胞可预防酵母聚糖 A 的抗抑郁作用。基于酵母聚糖 A 的这些作用,酵母聚糖 A 的给药可以开发为治疗抑郁症的新策略。

相似文献

1
Zymosan A produces a rapid and sustained antidepressant effect in chronically stressed mice by stimulating hippocampal microglia.酵母聚糖 A 通过刺激海马小胶质细胞在慢性应激小鼠中产生快速而持久的抗抑郁作用。
Behav Pharmacol. 2023 Sep 1;34(6):318-329. doi: 10.1097/FBP.0000000000000738. Epub 2023 Aug 2.
2
Microglia-Dependent Reversal of Depression-Like Behaviors in Chronically Stressed Mice by Administration of a Specific Immuno-stimulant β-Glucan.特定免疫刺激剂β-葡聚糖通过调节小胶质细胞逆转慢性应激小鼠的抑郁样行为。
Neurochem Res. 2024 Feb;49(2):519-531. doi: 10.1007/s11064-023-04056-x. Epub 2023 Nov 14.
3
Antidepressive properties of microglial stimulation in a mouse model of depression induced by chronic unpredictable stress.慢性不可预测应激诱导的抑郁模型中小胶质细胞刺激的抗抑郁作用。
Prog Neuropsychopharmacol Biol Psychiatry. 2020 Jul 13;101:109931. doi: 10.1016/j.pnpbp.2020.109931. Epub 2020 Mar 19.
4
Antidepressive properties of macrophage-colony stimulating factor in a mouse model of depression induced by chronic unpredictable stress.巨噬细胞集落刺激因子在慢性不可预测应激诱导的小鼠抑郁模型中的抗抑郁特性
Neuropharmacology. 2020 Aug 1;172:108132. doi: 10.1016/j.neuropharm.2020.108132. Epub 2020 May 12.
5
Intranasal Monophosphoryl Lipid a Administration Ameliorates depression-like Behavior in Chronically Stressed Mice Through Stimulation of Microglia.鼻内单磷酰脂质 A 给药通过刺激小胶质细胞改善慢性应激小鼠的抑郁样行为。
Neurochem Res. 2023 Oct;48(10):3160-3176. doi: 10.1007/s11064-023-03974-0. Epub 2023 Jun 26.
6
Identification of a microglial activation-dependent antidepressant effect of amphotericin B liposome.鉴定两性霉素 B 脂质体的小胶质细胞激活依赖性抗抑郁作用。
Neuropharmacology. 2019 Jun;151:33-44. doi: 10.1016/j.neuropharm.2019.04.005. Epub 2019 Apr 4.
7
Microglia stimulation produces antidepressant-like effects in a mouse depression model induced by adolescent chronic unpredictable stress.在青少年慢性不可预测应激诱导的小鼠抑郁模型中,小胶质细胞刺激产生抗抑郁样效应。
Physiol Behav. 2025 Mar 15;291:114782. doi: 10.1016/j.physbeh.2024.114782. Epub 2024 Dec 12.
8
β-glucan, a specific immuno-stimulant, produces rapid antidepressant effects by stimulating ERK1/2-dependent synthesis of BDNF in the hippocampus.β-葡聚糖是一种特定的免疫刺激剂,通过刺激海马体内 ERK1/2 依赖性 BDNF 的合成,产生快速的抗抑郁作用。
Eur J Pharmacol. 2023 Dec 15;961:176161. doi: 10.1016/j.ejphar.2023.176161. Epub 2023 Nov 7.
9
Intranasal administration of lipopolysaccharide reverses chronic stress-induced depression-like behavior in mice by microglial stimulation.鼻腔内给予脂多糖通过刺激小胶质细胞逆转慢性应激诱导的小鼠抑郁样行为。
Int Immunopharmacol. 2023 Jul;120:110347. doi: 10.1016/j.intimp.2023.110347. Epub 2023 Jun 2.
10
Intranasal LAG3 antibody infusion induces a rapid antidepressant effect via the hippocampal ERK1/2-BDNF signaling pathway in chronically stressed mice.鼻腔给予 LAG3 抗体可通过慢性应激小鼠海马 ERK1/2-BDNF 信号通路快速发挥抗抑郁作用。
Neuropharmacology. 2024 Nov 15;259:110118. doi: 10.1016/j.neuropharm.2024.110118. Epub 2024 Aug 15.

引用本文的文献

1
Disruption of positive- and negative-feature morphine interoceptive occasion setters by dopamine receptor agonism and antagonism in male and female rats.多巴胺受体激动剂和拮抗剂对雄性和雌性大鼠正性和负性吗啡内感受触发特征的干扰。
Psychopharmacology (Berl). 2024 Aug;241(8):1597-1615. doi: 10.1007/s00213-024-06584-y. Epub 2024 Apr 6.